Emergent BioSolutions Inc. EBS
5.05 USD -0.10 (-1.94%)
Regular-session close
5.12 +0.07 +1.39%
After hours · Nov 20, 5:14 PM ET
4.98 Day range 5.24
4.36 52-week range 14.06
- YTD
- -59.14%
- 1 year
- -44.38%
Revenue & Expenses
Revenue by
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 742.90M | 1.04B | 1.05B | 1.12B | 1.77B | |
| 742.90M | 1.04B | 1.05B | 1.12B | 1.77B | |
| 326.20M | 681.30M | 705.40M | 693.10M | 748.10M | |
| 416.70M | 362.30M | 343.90M | 424.40M | 1.03B | |
| 316.60M | 471.00M | 1.07B | 594.40M | 684.10M | |
| 53.20M | 70.70M | 111.40M | 188.30M | 235.20M | |
| 186.10M | 308.00M | 368.40M | 339.50M | 348.70M | |
| 100.10M | -108.70M | -726.40M | -170.00M | 341.40M | |
| 59.30M | 71.00M | 87.90M | 37.30M | 34.50M | |
| 30.20M | 47.70M | 29.30M | -7.40M | 83.70M | |
| 52.60M | -190.60M | -760.50M | -211.60M | 219.50M | |
| 52.60M | -190.60M | -760.50M | -211.60M | 219.50M | |
| 52.60M | -190.60M | -760.50M | -211.60M | 219.50M | |
| 52.60M | -190.60M | -760.50M | -211.60M | 219.50M | |
| 0.98 | -3.60 | -14.85 | -4.22 | 4.10 | |
| 0.98 | -3.60 | -14.85 | -4.22 | 4.10 | |
| 0.93 | -3.60 | -14.85 | -4.22 | 4.06 | |
| 142.10M | -71.90M | -643.30M | -181.70M | 337.70M | |
| 142.10M | -71.90M | -643.30M | -181.70M | 337.70M | |
| 53.50M | 53.00M | 51.20M | 50.10M | 53.50M | |
| 56.70M | 53.00M | 51.20M | 50.10M | 54.10M |
